Carlyle to buy Baxter's kidney-care spinoff Vantive for $3.8 billion

By Yahoo! Finance | Aug 13, 2024 at 07:16 AM EST

Carlyle Group acquires Baxter's kidney-care unit Vantive for $3.8 billion to help Baxter reduce debt. The deal is expected to close by early 2025, following Baxter's exploration of options for its kidney-care units after acquiring Hill-Rom in 2022.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.